<DOC>
	<DOCNO>NCT00048971</DOCNO>
	<brief_summary>RATIONALE : Genetic testing may help predict patient respond chemotherapy drug may help doctor plan effective treatment few side effect . PURPOSE : Genetic study determine gene affect severity diarrhea patient stage III colon cancer receive chemotherapy .</brief_summary>
	<brief_title>Genetic Trial Study Diarrhea Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether presence 7 allele UGT1A1 locus associate either grade 3-4 diarrhea grade 4 neutropenia patient stage III colon cancer treatment irinotecan , fluorouracil , leucovorin calcium . - Determine whether polymorphisms TS enhancer and/or MTHFR gene associate grade 3-4 diarrhea patient treatment fluorouracil leucovorin calcium . - Determine whether polymorphisms UGT1A1 , TS , MTHFR , CYP3A4 , CYP3A5 associate either grade 3-4 diarrhea grade 4 neutropenia patient treatment irinotecan , fluorouracil , leucovorin calcium . OUTLINE : Patients stratify accord prior therapy ( irinotecan , fluorouracil , leucovorin calcium v fluorouracil leucovorin calcium ) prior toxic effect ( grade 3-4 diarrhea v grade 4 neutropenia v grade 1 low diarrhea AND grade 2 low neutropenia ) . Patients undergo collection blood specimen polymerase chain reaction restriction fragment length polymorphism analysis . Genotyping assay perform determine UGT1A1 promoter genotyping , UGT1A1 cod polymorphism , TS promoter polymorphism , MTHFR polymorphism .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage III adenocarcinoma colon Enrolled CALGB89803 must fall 1 follow category : Received irinotecan , fluorouracil , leucovorin calcium experience least 1 follow : Grade 34 diarrhea Grade 4 neutropenia Grade 1 low diarrhea AND grade 2 low neutropenia Received fluorouracil leucovorin calcium experience least 1 follow : Grade 34 diarrhea Grade 1 low diarrhea AND grade 2 low neutropenia PATIENT CHARACTERISTICS : Age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>diarrhea</keyword>
	<keyword>neutropenia</keyword>
</DOC>